Tristel plc (AIM:TSTL)

Market Cap	176.53M
Revenue (ttm)	43.56M
Net Income (ttm)	6.14M
Shares Out	47.71M
EPS (ttm)	0.13
PE Ratio	28.72
Forward PE	21.42
Dividend	0.14 (3.65%)
Ex-Dividend Date	Mar 20, 2025

Volume	82,221
Average Volume	66,385
Open	374.00
Previous Close	370.00
Day's Range	360.00 - 374.00
52-Week Range	260.00 - 510.00
Beta	0.17
RSI	47.58
Earnings Date	May 23, 2025

About Tristel

Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom, Australia, Germany, Western Europe, and internationally. The company operates through three segments, Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other. It offers device decontamination products, including wipes system, ULT, OPH, Stella system, fuse for Stella, rinse assure, clean, EVE, medistel, EVA system, daisygrip, fuse for surfaces, dosing system, airstel, enzystel, DOK, pre-clean wipes, rinse wip...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1993
• Employees: 233
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: TSTL

Financial Performance

In 2024, Tristel's revenue was 41.93 million, an increase of 16.45% compared to the previous year's 36.01 million. Earnings were 6.49 million, an increase of 45.46%.